Liu Hao Peter
SEC CIK 1925315 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SONM | DNA X, Inc. | CEO, Dir | 269.4K | $800.0K | — | 3 | 2022-07-13 | 2025-02-06 |
Most active insiders at SONM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Crolius Clayton | CFO | — | — |
| 2 | MULICA MICHAEL C | Acting CEO, Dir | — | — |
Liu Hao Peter made no open-market trades at SONM in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-10 | 2025-02-06 | SONM | DNA X, Inc. | Liu Hao Peter | CEO, Dir | A - Grant | $0.00 | +63.6K | 269.4K | +31% | $0 | |
| D | 2023-08-23 | 2023-08-23 | SONM | DNA X, Inc. | Liu Hao Peter | CEO, Dir | M - OptEx | $0.42 | +1.00M | 2.06M | +95% | +$420.0K |
| 2022-07-14 | 2022-07-13 | SONM | DNA X, Inc. | Liu Hao Peter | CEO, Dir | P - Purchase | $0.84 | +952.4K | 1.06M | +886% | +$800.0K |
Purchase Sale Sale after option exercise All abbreviations